Revenue: The sum of all revenue fields included for a company's operating activities.
Mersana Therapeutics, Inc. (MRSN) had Revenue of $2.75M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$2.75M |
$-24.12M |
|
-- |
|
$2.75M |
|
$27.27M |
|
$-24.51M |
|
$0.39M |
|
$-24.12M |
|
$-24.12M |
|
$-24.12M |
|
$-24.12M |
|
$-24.12M |
|
$-24.12M |
|
$-24.51M |
|
$-24.34M |
|
124.47M |
|
124.47M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$106.19M |
|
$1.89M |
|
$6.28M |
|
$112.47M |
|
$58.16M |
|
$7.90M |
|
$85.18M |
|
$143.34M |
|
$-30.87M |
|
$-30.87M |
|
$-30.87M |
|
124.63M |
|
| Cash Flow Statement Financials | |
$-29.33M |
|
$27.00M |
|
$-3.14M |
|
$108.23M |
|
$102.77M |
|
$-5.46M |
|
$2.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.83 |
|
-- |
|
-- |
|
-0.34 |
|
-0.66 |
|
100.00% |
|
-890.05% |
|
-890.05% |
|
-- |
|
-875.93% |
|
-875.93% |
|
$-29.33M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
78.15% |
|
78.15% |
|
-21.45% |
|
105.03% |
|
$-0.25 |
|
$-0.24 |
|
$-0.24 |
|